|
🐜
|
Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy
13 auth.
J. Harper,
I. Ahmed,
G. Barclay,
M. Lacour,
Hoeger Ph,
M. Cork,
A. Finlay,
N. Wilson,
R. Graham‐Brown,
J. Sowden,
...
A. Beard,
M. J. Sumner,
J. Berth‐Jones
|
8 |
2000 |
8
🐜
|
|
🐜
|
A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis
8 auth.
L. Fuller,
Catherine Smith,
R. Cerio,
R. Marsden,
G. Midgley,
A. Beard,
...
E. Higgins,
R. Hay
|
6 |
2001 |
6
🐜
|
|
🐜
|
66 POTENT ANTIVIRAL ACTIVITY OF THE HCV NUCLEOSIDE POLYMERASE INHIBITOR R7128 WITH PEG-IFN AND RIBAVIRIN: INTERIM RESULTS OF R7128 500MG BID FOR 28 DAYS
13 auth.
J. Lalezari,
E. Gane,
M. Rodríguez-Torres,
E. D. Jesús,
D. Nelson,
G. Everson,
I. Jacobson,
R. Reddy,
G. Hill,
A. Beard,
...
W. Symonds,
M. Berrey,
J. Mchutchison
|
6 |
2008 |
6
🐜
|
|
🐜
|
Safety, Pharmacokinetics, and Efficacy of (+/−)-β-2′,3′-Dideoxy-5-Fluoro-3′-Thiacytidine with Efavirenz and Stavudine in Antiretroviral-Naïve Human Immunodeficiency Virus-Infected Patients
10 auth.
Christian Herzmann,
K. Arastéh,
Robert L. Murphy,
H. Schulbin,
P. Kreckel,
D. Drauz,
...
R. Schinazi,
A. Beard,
Leanne Cartee,
Michael Otto
|
3 |
2005 |
3
🐜
|
|
🐜
|
Potent Antiviral Effect of Reverset™ in HIV-1-Infected Adults following a Single Oral Dose
10 auth.
L. Stuyver,
Tamara R. Mcbrayer,
D. Schürmann,
I. Kravec,
A. Beard,
L. Cartee,
...
R. Schinazi,
A. D. Rosa,
R. Murphy,
M. Otto
|
3 |
2003 |
3
🐜
|
|
🐜
|
958 NO EVIDENCE OF R7128 DRUG RESISTANCE AFTER UP TO 4 WEEKS TREATMENT OF GT 1, 2 AND 3 HEPATITIS C VIRUS INFECTED INDIVIDUALS
8 auth.
S. Pogam,
A. Seshaadri,
A. Kosaka,
Steven Hu,
A. Beard,
S. Julian,
...
C. Nick,
I. Nájera
|
3 |
2009 |
3
🐜
|
